What is an Abbreviated New Drug Application (ANDA)?
An ANDA is submitted for the approval of a generic drug. Unlike an NDA, an ANDA does not require clinical trial data to demonstrate safety and efficacy. Instead, it must show that the generic drug is bioequivalent to the already approved brand-name drug, meaning it delivers the same amount of active ingredients into a patient’s bloodstream in the same amount of time.